"Sylvester Comprehensive Cancer Center is the only university-based comprehensive cancer center and only NCI-designated cancer center in the region. With more treatment options and more clinical trials than most hospitals in the southeastern United States, Sylvester is advancing cancer care in the region and beyond — all in pursuit of your cure. Teams of physicians and scientists work together to move discoveries from Sylvester's labs to patients and out into the community. As the home to South Florida's only Phase 1 Clinical Trials program, Sylvester offers novel treatments and hope to patients with rare forms of cancer."

During the past decade, UM Sylvester Comprehensive Cancer Center at Coral Springs conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Sylvester Comprehensive Cancer Center at Coral Springs" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UM Sylvester Comprehensive Cancer Center at Coral Springs" are "Acute Lymphoblastic Leukemia" (1 trials), "Advanced Malignant Solid Neoplasm" (1 trials), "B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative" (1 trials), "Basaloid Squamous Cell Carcinoma" (1 trials) and "Bladder Carcinoma" (1 trials). Many other conditions were trialed in "UM Sylvester Comprehensive Cancer Center at Coral Springs" in a lesser frequency.

Most popular intervention types in "UM Sylvester Comprehensive Cancer Center at Coral Springs" are "Drug" (4 trials), "Biological" (3 trials), "Procedure" (3 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (2 trials), "Adavosertib" (1 trials), "Afatinib" (1 trials), "Afatinib Dimaleate" (1 trials) and "Allogeneic Hematopoietic Stem Cell Transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "UM Sylvester Comprehensive Cancer Center at Coral Springs" are 6 trials for "All" genders.

Currently, there are NaN active trials in "UM Sylvester Comprehensive Cancer Center at Coral Springs". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UM Sylvester Comprehensive Cancer Center at Coral Springs, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UM Sylvester Comprehensive Cancer Center at Coral Springs, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".